New stent study aims to keep hearts beating strong in thousands

NCT ID NCT03443999

First seen Apr 29, 2026

Summary

This study is testing a special drug-coated stent (Supraflex) in 10,000 people with coronary artery disease. The stent is placed in blocked heart arteries to keep them open and slowly release medicine to prevent re-blockage. Researchers will track heart-related deaths, heart attacks, and the need for repeat procedures over time to see how safe and effective the stent is in everyday medical practice.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Albert Schweitzer Ziekenhuis

    RECRUITING

    Dordrecht, South Holland, Post bus 444 3300 AK, Netherlands

  • Amphia Ziekenhuis

    RECRUITING

    Breda, North Brabant, 4818 CK Breda, Netherlands

  • Catharina Ziekenhuis

    RECRUITING

    Eindhoven, North Brabant, 5623 EJ, Netherlands

  • Maasstad Ziekenhuis

    RECRUITING

    Rotterdam, South Holland, 3079 DZ, Netherlands

  • Medical Center Leeuwarden

    RECRUITING

    Leeuwarden, Provincie Friesland, 8934 AD, Netherlands

  • Tergooi Ziekenhuis

    RECRUITING

    Blaricum, North Holland, 1261 AN, Netherlands

  • ZorgSaam Hospital

    RECRUITING

    Terneuzen, Zeeuws- Vlaanderen, 4535 PA, Netherlands

Conditions

The condition(s) this trial relates to.

coronary artery disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.